OncoSil Medical Limited (ASX:OSL)
Australia flag Australia · Delayed Price · Currency is AUD
0.0040
0.00 (0.00%)
Apr 4, 2025, 3:36 PM AEST

OncoSil Medical Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Market Capitalization
181324404295
Upgrade
Market Cap Growth
55.21%-43.79%-40.20%-6.18%-55.65%185.06%
Upgrade
Enterprise Value
10918332489
Upgrade
Last Close Price
0.000.000.010.030.040.09
Upgrade
PS Ratio
6.758.5116.1637.2832.5534.48
Upgrade
PB Ratio
2.152.812.403.553.614.35
Upgrade
P/TBV Ratio
3.222.812.403.553.614.35
Upgrade
EV/Sales Ratio
5.255.4612.3931.4018.7832.10
Upgrade
Debt / Equity Ratio
0.010.020.020.030.040.01
Upgrade
Asset Turnover
0.210.170.120.080.070.16
Upgrade
Quick Ratio
3.613.066.816.896.2911.03
Upgrade
Current Ratio
3.823.267.167.216.3911.08
Upgrade
Return on Equity (ROE)
-199.38%-163.01%-107.80%-93.85%-62.11%-26.17%
Upgrade
Return on Assets (ROA)
-87.77%-82.34%-57.73%-48.58%-34.49%-15.50%
Upgrade
Return on Capital (ROIC)
-122.79%-100.82%-65.85%-55.91%-38.54%-16.95%
Upgrade
Earnings Yield
-68.40%-89.39%-47.84%-27.05%-24.69%-4.47%
Upgrade
FCF Yield
-69.69%-82.69%-47.97%-25.52%-20.99%-4.70%
Upgrade
Buyback Yield / Dilution
-98.53%-96.48%-39.32%0.89%-24.68%-4.40%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.